Xenon Pharmaceuticals Inc. (XENE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Xenon Pharmaceuticals Inc...

    NASDAQ: XENE · Real-Time Price · USD
    37.05
    -0.17 (-0.46%)
    At close: Sep 12, 2025, 9:53 AM

    Xenon Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 9.43M 18.44M
    Cost of Revenue
    		 2.56M 167.51M 105.77M 75.46M
    Gross Profit
    		 -2.56M -167.51M -96.33M -57.03M
    Operating Income
    		 -279.3M -214.05M -129.14M -78.99M
    Interest Income
    		 41.94M 27.62M 8.71M 466K
    Pretax Income
    		 -238.42M -182.69M -125.25M -78.89M
    Net Income
    		 -234.33M -182.39M -125.37M -78.88M
    Selling & General & Admin
    		 68.9M 46.54M 32.81M 21.97M
    Research & Development
    		 210.39M 167.51M 105.77M 75.46M
    Other Expenses
    		 -2.56M -167.51M 3.89M 105K
    Operating Expenses
    		 276.74M 46.54M 138.58M 97.43M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 279.3M 214.05M 138.58M 97.43M
    Income Tax Expense
    		 -4.09M -292K 118K -6K
    Shares Outstanding (Basic)
    		 77.89M 66.89M 60.54M 43.63M
    Shares Outstanding (Diluted)
    		 77.89M 66.89M 60.54M 43.63M
    EPS (Basic)
    		 -3.01 -2.73 -2.07 -1.81
    EPS (Diluted)
    		 -3.01 -2.73 -2.07 -1.81
    EBITDA
    		 -235.86M -210.51M -127.52M -78.09M
    EBIT
    		 -238.42M -214.05M -129.14M -78.99M
    Depreciation & Amortization
    		 2.56M 3.54M 1.62M 906K

    Add to Watchlist